Skip to content

A long - term follow - up trial of A prospective, multi - center, randomized, non - treatment - controlled, assessor - blinded, superiority clinical trial to evaluate the safety and efficacy of a collagen injection filler containing sodium hyaluronate for correcting infraorbital depression.

A long - term follow - up trial of A prospective, multi - center, randomized, non - treatment - controlled, assessor - blinded, superiority clinical trial to evaluate the safety and efficacy of a collagen injection filler containing sodium hyaluronate for correcting infraorbital depression.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108964
Enrollment
Unknown
Registered
2025-09-09
Start date
2025-05-21
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infraorbital depression

Interventions

Experimental group:None

Sponsors

Guangdong Second Provincial General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. "A prospective, multicenter, randomized, controlled, evaluator-blinded, superiority clinical trial on the safety and efficacy of a hyaluronic acid-containing collagen injection filler for correcting infraorbital hollows" (Trial No. JT202502WX) enrolled and treated the trial group study participants; 2. The study participants understood the clinical trial and agreed to participate, voluntarily signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Researchers believe that those who are not suitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Blinded Investigator Scoring for AIHS (Infraorbital Hollow Severity Scale)?;

Secondary

MeasureTime frame
Injector-investigator Scoring for AIHS (Infraorbital Hollow Severity Scale);Satisfaction evaluation;

Countries

China

Contacts

Public ContactLuo Shengkang

Guangdong Second Provincial General Hospital

luoshengkang63@hotmail.com+86 137 1909 5959

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026